Skip to main content
. 2022 Jan 12;8:815628. doi: 10.3389/fmed.2021.815628

Table 3.

Imaging appearance of 233 recurrence of ovarian endometrioma according to the presence of adenomyosis.

Subtype II (n = 112) Other types of adenomyosis
(n = 55)
Non-adenomyosis (n = 66) P- value
Presence of posterior external lesion (n, %) 100 (89.29) 30 (54.44) - 0.021
Size of the posterior external lesion (mm) 38.87 ± 8.17 27.07 ± 4.46 - 0.016
Presence of the anterior external lesion (n, %) 12 (10.71) 25(45.46) - 0.018
Size of the anterior external lesion (mm) 21.14 ± 5.53 18.89 ± 4.36 - 0.029
JZ zone thickness, mm 7.46 ± 4.83 12.25 ± 2.62 5.47 ± 1.21 0.022
Myometrium thickness, mm 15.77 ± 5.61 16.79 ± 5.94 14.82 ± 4.18 0.46
Junctional zone/myometrium ratio 0.46 ± 0.22 0.78 ± 0.35 0.37 ± 0.16 <0.01
Presence of leiomyomas (n, %) 15 (13.39) 8 (14.55) 9 (13.64) 0.77
Uterine volume, cm3 257.37 ± 42.61 203.14 ± 33.52 100.85 ± 26.67 <0.01
Presence of endometrioma (n, %)
Bilateral 63 (56.25) 28 (50.90) 19 (28.79) 0.22
Unilateral 49 (43.75) 27 (49.10) 47 (71.21) 0.37
Right 20 17 20
Center 29 20 27
Mean OMA size, cm 4.97 ± 2.25 4.36 ± 2.38 4.46 ± 2.70 0.031
Right 4.49 ± 2.21 3.91 ± 2.81 4.71 ± 2.62 0.042
Center 5.01 ± 2.13 4.79 ± 2.34 4.22 ± 2.46 0.029

Data are presented as means ± the standard deviation and n (%) as appropriate. Kruskal–Wallis followed by post-hoc Dunn's test or ANOVA test; χ2-test or Fisher's exact test; p < 0.05.